# A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects

> **NCT05758818** · PHASE1 · TERMINATED · sponsor: **Rain Oncology Inc** · enrollment: 6 (actual)

## Conditions studied

- Cardiac Repolarization

## Interventions

- **DRUG:** Placebo
- **DRUG:** Moxifloxacin (positive control)
- **DRUG:** Milademetan

## Key facts

- **NCT ID:** NCT05758818
- **Lead sponsor:** Rain Oncology Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-17
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-06-08
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** sponsor decision
- **Last updated:** 2023-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758818, "A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05758818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*